VijayGaneshSankaranMDPhD
Pediatric Hematology & Oncology • Boston, MAAttending Physician in Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Lodish Family Chair, Boston Children's Hospital; Jan Ellen Paradise, MD Associate Professor of Pediatrics, Harvard Medical School
Dr. Sankaran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Avenue
Boston, MA 02115Phone+1 617-355-6000
Summary
- Dr. Vijay Sankaran is a pediatric hematologist/oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Boston Children's Hospital, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and the Beth Israel Deaconess Hospital. He received his medical degree from Harvard Medical School and has been in practice 12 years. He is experienced in pediatric hematology/oncology, including in thalassemia, sickle cell disease, bone marrow failure syndromes, genetic predisposition to blood cancers, and other disorders impacting hematopoiesis.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2015- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2010 - 2013
Harvard Medical SchoolClass of 2010
Certifications & Licensure
MA State Medical License 2013 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- Evolution of myeloproliferative neoplasms from normal blood stem cells.Sahand Hormoz, Vijay G Sankaran, Ann Mullally
Haematologica. 2025-04-01 - The bleeding edge: broadening horizons for hematopoietic stem cell therapies.Spencer D Shelton, Vijay G Sankaran
Trends in Molecular Medicine. 2025-03-21 - A torpor-like state in mice slows blood epigenetic aging and prolongs healthspan.Lorna Jayne, Aurora Lavin-Peter, Julian Roessler, Alexander Tyshkovskiy, Mateusz Antoszewski
Nature Aging. 2025-03-01
Press Mentions
Novel Genomic Screening Tool Enables Precision Reverse-Engineering of Genetic Programming in CellsApril 4th, 2025
Episode 1: The First CRISPR Medicine for Sickle Cell DiseaseFebruary 20th, 2025
Creating the World’s First CRISPR Medicine, for Sickle Cell DiseaseFebruary 20th, 2025- Join now to see all
Grant Support
- Variant to Function Mapping of B-ALL Risk LociBOSTON CHILDREN'S HOSPITAL2024–2029
- Systematic Genetic Dissection of Human ErythropoiesisBOSTON CHILDREN'S HOSPITAL2014–2029
- Selective pressures from inherited variation impacting myeloproliferative neoplasm initiationBOSTON CHILDREN'S HOSPITAL2022–2027
- Clonal analysis of cancer by mitochondrial DNA barcodingBRIGHAM AND WOMEN'S HOSPITAL2023–2026
- Hemoglobin Switching MeetingBOSTON CHILDREN'S HOSPITAL2024–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
